A study by Israel’s largest healthcare provider on Sunday found that participants received two doses of coronavirus vaccine against Pfizer, according to a report a 94% drop in symptomatic COVID-19 infections.
Clalit, the health care system that covers most Israelis, compares 600,000 people who have received both doses of Pfizer vaccine against a group of the same size that is consistent with medical history and has not yet received the vaccine.
The study found that people in the group were also 92% less likely to develop serious illnesses due to the virus after getting both jabs, according to Reuters.
UK CORONAVIRUS VARIANT THAT COULD BE DEADLY IN OURSELVES, S SC SCIENTISTS
Dry ice is poured into a box containing the Pfizer-BioNTech COVID-19 vaccine as it is ready to be shipped to the Pfizer Global Supply Kalamazoo plant in Portage, Mich., Sunday, December 13, 2020. (AP Photo / Morry Gash, pool)
The data are almost consistent with Pfizer’s Phase 3 clinical trial, which shows that the vaccine is 95% effective.
“It shows unequivocally that Pfizer’s coronavirus vaccination is extremely effective in the real world a week after the second dose, just as it appears in the clinical study,” said Ral Balicer, head of innovation at Clalit.
Balicer added that the data showed that the Pfizer vaccine, developed in collaboration with German BioNTech, was even more ‘effective’ two weeks or more after the second survey, the news organization reported.
According to Bloomberg’s COVID-19 vaccine researcher, Israel is undergoing rapid vaccination, leading all countries with approximately 70.5 doses per 100 people.
WHITE HOUSE FALLS TO SAY IF ISRAEL IS AN ‘IMPORTANT’ ALLY
Meanwhile, for the first time, there has also been a sharp decline in hospitalization and serious illness in people aged 55 and older, said researchers from the Weizmann Institute of Science, which mapped national data.
CLICK HERE FOR THE FOX NEWS APP
As of early Monday, Israel has reported more than 727,485 total coronavirus infections and at least 5,403 deaths from the virus since the pandemic began, according to Johns Hopkins University data.